Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared FDA Oncology’s post on X, adding:
“Just learnt of this session.
Important issues facing patients with papillary disease bladder cancer and patients facing shortage of BCG.
These are the issues I have been discussing with FDA for a long time and will address them at our AUA talk on Saturday.
Will livestream and share the presentation thereafter. Stay tuned.”
Quoting FDA Oncology’s post:
“Upcoming Workshop: Contemporary Issues in Non-Muscle Invasive Bladder Cancer (NMIBC) Trial Design and Interpretation.
Join the FDA Oncology Center of Excellence for a workshop exploring key challenges and advances in NMIBC research.”
Contemporary Issues in Non-Muscle Invasive Bladder Cancer (NMIBC) Trial Design and Interpretation
Other articles featuring Pat Soon-Shiong and FDA Oncology on OncoDaily.